Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antiretroviral Agents”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00039663
What this trial is testing

Endothelial Dysfunction as a Risk Factor in HIV Study

Who this might be right for
HIV Infections
National Institutes of Health Clinical Center (CC) 75
Large-scale testing (Phase 3)Study completedNCT01499199
What this trial is testing

The Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 13
Large-scale testing (Phase 3)Study completedNCT00196612
What this trial is testing

Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAART

Who this might be right for
HIV Infections
ANRS, Emerging Infectious Diseases 350
Large-scale testing (Phase 3)Study completedNCT00098293
What this trial is testing

Trial of Maraviroc (UK-427,857) in Combination With Zidovudine/Lamivudine Versus Efavirenz in Combination With Zidovudine/Lamivudine

Who this might be right for
HIV-1
ViiV Healthcare 916
Large-scale testing (Phase 3)Study completedNCT04001803
What this trial is testing

Study to Identify and Determine Best Implementation Practices for Injectable Cabotegravir+Rilpivirine in the United States (US)

Who this might be right for
HIV Infections
ViiV Healthcare 115
Not applicableStudy completedNCT02309372
What this trial is testing

Depression Therapy to Improve Cardiovascular Risk in HIV

Who this might be right for
DepressionHIV
Indiana University 54
Not applicableStudy completedNCT04080765
What this trial is testing

Antiretroviral Therapy Selection: Comparing HIV Clinical Guidelines With HIV-ASSIST, an Online Decision-support Tool

Who this might be right for
Hiv
Johns Hopkins University 138
Post-approval studies (Phase 4)Study completedNCT01599364
What this trial is testing

Atazanavir/r + Lamivudine Dual Therapy

Who this might be right for
Human Immunodeficiency Virus
Catholic University of the Sacred Heart 266
Not applicableStudy completedNCT01061957
What this trial is testing

Raltegravir Treatment in Patients Failing Highly Active Antiretroviral Therapy (HAART) in Denmark

Who this might be right for
HIV Infections
Rigshospitalet, Denmark 96
Large-scale testing (Phase 3)Study completedNCT00990600
What this trial is testing

QoL and Adherence to One-pill Once-a-day HAART

Who this might be right for
HIV InfectionHIV Infections
A.O. Ospedale Papa Giovanni XXIII 212
Not applicableStudy completedNCT02063880
What this trial is testing

Pediatric Urgent Start of Highly Active Antiretroviral Treatment (HAART)

Who this might be right for
Human Immunodeficiency VirusImmune Reconstitution Inflammatory Syndrome
University of Washington 183
Not applicableActive Not RecruitingNCT06451341
What this trial is testing

IMplementation of CAB+RPV LA for People With HIV in Non-Metropolitan Areas

Who this might be right for
HIV
University of Nebraska 75
Testing effectiveness (Phase 2)Ended earlyNCT00122512
What this trial is testing

Study of Tenofovir Disoproxil Fumarate (TDF) for Prevention of HIV

Who this might be right for
HIV Infections
FHI 360 500
Not applicableStudy completedNCT01524900
What this trial is testing

Observational Study of Nevirapine Extended Release in Human Immunodeficiency Virus (HIV) Patients in Daily Clinical Practice

Who this might be right for
HIV Infections
Boehringer Ingelheim 398
Testing effectiveness (Phase 2)Ended earlyNCT01199731
What this trial is testing

Dose-finding Study of GSK2248761 in Antiretroviral Therapy-experienced Subjects With NNRTI-resistant HIV Infection

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 30
Not applicableUnknownNCT01433601
What this trial is testing

Antiretroviral Treatment Strategies in Relation to Adherence, Resistance and Virological Treatment Failure

Who this might be right for
Human Immunodeficiency Virus (HIV)
Karolinska Institutet 640
Not applicableStudy completedNCT00814879
What this trial is testing

Pilot Study of a Raltegravir Based NRTI Sparing Regimen

Who this might be right for
Acquired Immune Deficiency SyndromeAIDSHuman Immunodeficiency Virus+1 more
Yale University 60
Not applicableStudy completedNCT02891135
What this trial is testing

Simplified Algorithm for Treatment Eligibility

Who this might be right for
HIV
Boston University 1,077
Testing effectiveness (Phase 2)Study completedNCT00120185
What this trial is testing

Efficacy of Using Interleukin-2 in Antiretroviral Naïve HIV Patients (ANRS119)

Who this might be right for
HIV Infections
French National Agency for Research on AIDS and Viral Hepatitis 130
Post-approval studies (Phase 4)UnknownNCT04225325
What this trial is testing

Implication for Strategies of Long Term Control of Viral Replication in Patient With Primary HIV Infection (PHI).

Who this might be right for
HIV-1-infection
ADRIANO LAZZARIN, MD 112
Next Page